Reports for RISPERIDONE
Ingredient
RISPERIDONE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-RISPERIDONE | 0.25MG | TABLET | Resolved | 2017-08-31 | 2017-11-30 | 20707 |
| PRO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2017-08-24 | 2017-09-22 | 20226 |
| APO-RISPERIDONE | 0.25MG | TABLET | Resolved | 2017-08-23 | 2017-11-29 | 20122 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2017-07-26 | 2017-11-29 | 17319 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2017-06-28 | 2017-11-30 | 14219 |
| APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2017-06-28 | 2017-12-01 | 14216 |
| ACT RISPERIDONE | 2MG | TABLET | Actual shortage | 2017-05-24 | 2018-10-11 | 10984 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2017-05-10 | 2017-06-01 | 9906 |
| PRO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2017-05-09 | 2017-07-31 | 9735 |
| MYLAN-RISPERIDONE | 3.0MG | TABLET | Resolved | 2017-05-04 | 2017-10-03 | 9045 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118153 |
| PMS-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118150 |
| TARO-RISPERIDONE | 2.0MG | TABLET | Discontinued | 2020-02-02 | 2020-02-02 | 105101 |
| TARO-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2019-08-09 | 2019-08-10 | 91284 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |
| RISPERDAL | 4MG | TABLET | Discontinued | 2018-11-29 | 2019-04-02 | 68101 |
| RISPERDAL | 0.5MG | TABLET | Discontinued | 2018-11-29 | 2019-04-02 | 68098 |
| RISPERDAL | 0.25MG | TABLET | Discontinued | 2018-11-29 | 2019-04-02 | 68095 |
| RISPERDAL | 3MG | TABLET | Discontinued | 2018-11-29 | 2019-04-02 | 68092 |
| RISPERDAL | 2MG | TABLET | Discontinued | 2018-11-29 | 2019-04-02 | 68089 |